# A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery

> **NCT07751367** · NA · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Pancreatic Exocrine Insufficiency, Adul

## Interventions

- **DRUG:** High-dose group: Oryz-Aspergillus Enzyme and Pancreatin Tablet
- **DRUG:** Low-dose group: Oryz-Aspergillus Enzyme And Pancreatin Tablet

## Key facts

- **NCT ID:** NCT07751367
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-18
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751367, "A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07751367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*